Search All News
A new study in Amish people suggests that reducing the activity of a protein that regulates plasma triglycerides could prevent cardiovascular disease.
A study led by Columbia researchers found that a minimally invasive technique to repair the mitral valve improved two-year survival for certain heart failure patients.
A new study led by Columbia's Mathew Maurer found that tafamidis reduced deaths from transthyretin amyloid cardiomyopathy, a type of heart failure.
For women, even mild sleep problems can raise blood pressure, finds a new study.
- August 1, 2017
Aspirin does not increase the risk of hospitalization or death in patients taking ACE inhibitors or ARBs for heart failure, Columbia researchers have found.
- August 1, 2017
Using a noninvasive test developed at Columbia, older TAVR patients with an unusual heart failure pattern were found to have cardiac amyloidosis.
- May 1, 2017
Smoking counteracts the effect of a gene that normally protects against heart disease, according to a new study.
- March 6, 2017
Columbia University names cardiology researchers Muredach P. Reilly and Marwah Abdalla 2017 Marjorie and Lewis Katz Scholars.
- March 1, 2017
Researchers have found that only 16 percent of heart attack survivors get the recommended amount of physical activity in the weeks after hospitalization.
- January 20, 2017
A new study from Columbia University researchers estimates that 17 million Americans who have normal blood pressure in the doctor's office may have undiagnosed hypertension.
- December 20, 2016
Children who had heart surgery at NYP/CUMC had a significantly lower risk-adjusted mortality rate compared with all other New York state programs.
- December 9, 2016
Heart failure is no more common in individuals with sickle cell trait than in the general population, a new study has found.
- November 1, 2016
An international trial shows that TCEP, a procedure meant to reduce neurological complications, is safe for TAVR patients, though more research is needed on efficacy.
- October 31, 2016
A major international study has found that drug-eluting stents are as effective as surgery for many patients with a blockage in the left main coronary artery.